Steward Partners Investment Solutions »

Novo Nordisk A/S shares owned by Steward Partners Investment Solutions

Quarter-by-quarter ownership of Novo Nordisk A/S (NVO) shares owned by Steward Partners Investment Solutions from 13F filings

Historical chart of Steward Partners Investment Solutions investment in Novo Nordisk A/S

Tip: Access up to 7 years of quarterly data

All positions including Novo Nordisk A/S held by Steward Partners Investment Solutions consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novo Nordisk A/S by Steward Partners Investment Solutions

Quarter filed Position value Share count Share price at filing
2024-03-31 $318k 2.5k 128.40

More positions owned by Steward Partners Investment Solutions

Microsoft Corp Comstock (MSFT)
Apple Comstock (AAPL)
Vanguard Index Fds S&p 500 Etf Exchange Traded Fund (VOO)
Fidelity Comwlth Tr Nasdaq Composite Index Etf Exchange Traded Fund (ONEQ)
Nvidia Corp Common Stock (NVDA)
Amazon Common Stock (AMZN)
Wisdomtree Tr Japan Hedged Equity Exchange Traded Fund (DXJ)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Spdr S&p 500 Etf Tr Tr Unit Exchange Traded Fund (SPY)
Invesco Qqq Tr Unit Ser 1 Exchange Traded Fund (QQQ)
Jpmorgan Chase & Co Comstock (JPM)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)
Vanguard Specialized Funds Divid Appreciation Etf Exchange Traded Fund (VIG)
Uber Technologies Common Stock (UBER)
Select Sector Spdr Tr Financial Exchange Traded Fund (XLF)

View all positions for Steward Partners Investment Solutions

Top funds holding Novo Nordisk A/S

Jennison Associates
FMR
Bank of America Corporation
Fisher Investments
Fayez Sarofim & Co
T. Rowe Price Associates
Folketrygdfondet
Loomis, Sayles and
Renaissance Technologies
GQG Partners
Capital Research and Management Company - Division 3
Polen Capital Management
Everett Harris & Co
State Street Corporation
State Farm Mutual Automobile Insurance Company

View all funds holding Novo Nordisk A/S